Payment infrastructurefor compliant RUOis verified + sealed
SolRUO gives U.S. distributors of research-use-only compounds the counterparty verification, signed attestations, and tamper-evident audit trail that payment processors require.
Apply for AccessStrictly B2B · U.S.-only · 21 CFR §201.128
RUO distributors face a compliance gap mainstream processors won't cross.
Processor Risk
Mainstream payment processors flag research-use sales as restricted. Without documented preventive measures, accounts are frozen with no notice and funds held 90–180 days.
Compliance Exposure
Selling RUO compounds without a verified counterparty gate, signed attestations, and an audit trail exposes distributors to regulatory risk under 21 CFR §201.128 intended-use standards.
No Infrastructure
Most compliance tools are built for consumer markets. There is no purpose-built payment infrastructure for B2B RUO distribution — until now.
The compliance stack your processor is looking for.
SolRUO connects to each distributor's own Stripe account and enforces the preventive measures Stripe's own policy requires for research-use sales.
Counterparty Verification Gate
Every buyer must verify they are a qualified research counterparty — a licensed researcher, clinical laboratory, contract research organization, or credentialed institutional buyer — before accessing the storefront. No consumer access. No exceptions.
Signed Intended-Use Attestation
Each verified buyer signs a locked intended-use attestation aligned to 21 CFR §201.128 before any purchase. Attestation wording is standardized and cannot be weakened or removed by the distributor.
Tamper-Evident Audit Records
Every agreement is sealed into a cryptographically signed audit log — counterparty type, intended use, timestamp, IP, and signature hash. Exportable on demand for processor review.
Continuous Compliance Monitoring
SolRUO scans each connected storefront weekly for medical claims, human-use language, missing RUO disclaimers, and content that would trigger a processor review. Distributors receive a live compliance score and flagged line items to fix before a reviewer sees them.
Step 5 — Domestic-Only Enforcement
SolRUO restricts all connected storefronts to U.S.-based buyers only. Non-U.S. access is blocked at the counterparty verification gate before any product content loads. This cannot be overridden or disabled by individual merchants. All transactions process through U.S.-based Stripe accounts settling to U.S. bank accounts only.
Built on the preventive measures processors require.
Stripe's own policy permits research-use compounds when preventive measures ensure they are not accessible to those who would purchase for non-research purposes. SolRUO is those measures.
- 01Qualified-counterparty gateActive
- 02Signed intended-use attestation (21 CFR §201.128)Locked
- 03RUO and FDA disclaimer wordingEnforced
- 04Tamper-evident per-buyer audit recordSealed
- 05Weekly storefront compliance scanAutomated
- 06Domestic U.S. sales only — Non-U.S. access blocked at gateActive
- 07Exportable audit trail for processor reviewOn demand
SolRUO does not decide processor approval. Every connected account is independently underwritten by Stripe.
What SolRUO provides is the documented evidence trail — a verifiable record that every sale was made to a qualified counterparty, for an explicitly stated research purpose, with a signed agreement on file.
Built exclusively for B2B distributors of research-use-only compounds.
You qualify if
- You sell exclusively to licensed researchers, clinical labs, CROs, or credentialed institutional buyers
- Every product is labeled and marketed strictly for in vitro or laboratory research use
- You maintain Certificates of Analysis for every SKU
- You do not sell direct-to-consumer
- You do not make health, therapeutic, or performance claims
SolRUO does not support
- Direct-to-consumer sales
- Products marketed for human consumption
- Compounding pharmacies without proper licensing
- Businesses making health or wellness claims
- Merchants in jurisdictions where RUO distribution is prohibited
What we verify before onboarding
- Business entity and EIN confirmation
- Website compliance review against RUO standards
- Product labeling and CoA documentation
- Absence of prohibited health claims across all pages, metadata, and reviews
- Jurisdiction eligibility
- U.S.-based business entity only — international merchants not supported
Stay ahead of a processor review, every week.
SolRUO scans your connected storefront on a weekly schedule and returns a live compliance score with specific flagged items — before a processor review catches them first.
- MEDPossible therapeutic claim detected/products/compound-a
- LOWRUO disclaimer missing from footer/checkout
- —Gate confirmed active/OK
- —Attestation log current/auditOK
Compliance drift is the most common reason a clean account gets flagged during routine processor review. SolRUO makes drift visible and fixable before it becomes a problem. Your monitoring history exports as a clean report you can hand to a processor alongside your signed attestation ledger.
Transparent pricing. No hidden fees.
Standard
TIER / 01 · LIVENo monthly platform fee. Your standard Stripe processing fees apply separately.
- Counterparty verification gate
- Signed attestation capture
- Tamper-evident audit log
- Weekly compliance scan
- Jurisdiction controls
- Exportable audit trail
Enterprise
TIER / 02 · SOONFor high-volume distributors and multi-storefront operators.
- Dedicated compliance account manager
- Custom attestation wording review
- Priority processor liaison support
- Multi-storefront management
- Everything in Standard
SolRUO is compliance and payment infrastructure software. It is not a bank, payment processor, money services business, law firm, or regulatory authority. Payment processor approval is determined independently by Stripe and is not guaranteed by SolRUO.
Common questions.
Get the audit trail your processor is asking for.
Qualified RUO distributors are reviewed within 3 business days. No DTC. No consumer-facing storefronts. No exceptions.